Chronic Hepatitis B Pediatric Study
About Hepatitis B
Chronic Hepatitis B (CHB) is a global public health issue. If left untreated, CHB can cause serious health problems, like scarring of the liver and liver damage. According to CDC (Centers for Disease Control and Prevention), an estimated 862,000 people in the U.S. are chronically infected with the Hepatitis B Virus. An infected mother can pass it to her baby at birth.
About Our Study
This study is evaluating the safety and efficacy of an investigational drug in children and adolescents (ages 6 to <18 years) with chronic hepatitis B virus infection. If your child or loved one is less than 6 years of age, please email GS-USemail@example.com.
Why Participate in This Study?
- Eligible study participants may receive investigative study medication or placebo (an inactive substance)
- Participants will receive medical care for their Hepatitis B from a local study doctor at no cost and their health will be monitored closely at study visits
- Participants may be eligible to participate in a long-term extension study
- Participants may also receive reimbursement for study-related travel expenses
Confirm Your Age
To complete this pre-screening form, you must select YES to acknowledge that you are 18 years or older.
Please fill out the following survey to confirm your child or loved one is eligible to participate in this study. If your responses indicate that your child or loved one may qualify for this study, you will be provided with a list of clinics conducting the study.
GS-US-320-1092 – Chronic Hepatitis B Pediatric Study | Gilead
You have been selected to continue through this pre-qualification process.
Please select the state or province where, if qualified, your child or loved one will be attending regular study visits. Once you have selected a state or province, a list of qualified physicians will be presented; you will need to then contact the nearest facility to schedule your appointment.
Choose your closest state/territory
Sorry, Your Child or Loved One Is Not Eligible
Based on your selection(s), your child or loved one is not eligible to join this study. Thank you for your interest in participating in our clinical trials.